UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Estimating the cost-effectiveness profile of a universal vaccination programme with a nine-valent HPV vaccine in Austria

BMC infectious diseases, 2016-04, Vol.16 (153), p.153-153, Article 153

2016

Volltextzugriff (PDF)

Évaluation du coût de la prise en charge pédiatrique des gastroentérites aiguës à rotavirus

Archives de pédiatrie : organe officiel de la Société française de pédiatrie, 2008-07, Vol.15 (7), p.1159-1166

2008

Volltextzugriff (PDF)

Critical Review of Cost-Effectiveness Analyses (CEA) of Prevention Strategies Against Diseases Associated with Human Papillomavirus (HPV) Infection

Value in health, 2014-11, Vol.17 (7), p.A637-A637

2014

Volltextzugriff (PDF)

The Economic Value of Vaccination: Why Prevention Is Wealth

Value in health, 2014-11, Vol.17 (7), p.A450-A450

2014

Volltextzugriff (PDF)

Health and economic impact associated with a quadrivalent HPV vaccine in Italy

Gynecologic oncology, 2009-02, Vol.112 (2), p.370-376

2009

Volltextzugriff (PDF)

Épidémiologie et impact de la gastroentérite aiguë à rotavirus dans les crèches municipales de la ville de Lyon – saison 2004–2005

Archives de pédiatrie : organe officiel de la Société française de pédiatrie, 2008-07, Vol.15 (7), p.1183-1192

2008

Volltextzugriff (PDF)

PRM17 Economic Evaluation of Vaccines: Considerations on Evidence, Discounting, Models and Futures Challenges

Value in health, 2012-11, Vol.15 (7), p.A463-A463

2012

Volltextzugriff (PDF)

PIN60 Critical Review of Cost-Effectiveness Analyses of Human Papillomavirus Vaccine in Boys

Value in health, 2012-11, Vol.15 (7), p.A396-A396

2012

Volltextzugriff (PDF)

Herpes Zoster in Europe: A Review of Evidence Documenting Humanistic, Economic and Societal Burden

Value in health, 2013-11, Vol.16 (7), p.A622-A622

2013

Volltextzugriff (PDF)

Cost-Effectiveness Analysis of a Vaccination Programme for the Prevention of Herpes Zoster and Post-Herpetic Neuralgia in Adults Aged 50 and Over in Germany

Value in health, 2013-11, Vol.16 (7), p.A383-A383

2013

Volltextzugriff (PDF)

PIN66 A Scoping Review of the Literature on the Multifactorial Health-Economics Burden Caused By the COVID-19 Pandemic

Value in health, 2020-12, Vol.23, p.S556-S556

2020

Volltextzugriff (PDF)

PCN165 A First Estimate of the Incremental Impact of Males HPV Vaccination on HPV-Related Diseases in Europe

Value in health, 2011, Vol.14 (7), p.A464-A465

2011

Volltextzugriff (PDF)

Treatment patterns and associated costs for genital warts in Italy

Current medical research and opinion, 2008-11, Vol.24 (11), p.3175-3183

2008

Volltextzugriff (PDF)

Cost-effectiveness of vaccination against herpes zoster and postherpetic neuralgia: a critical review

Vaccine, 2014-03, Vol.32 (15), p.1645-1653

2014

Volltextzugriff (PDF)

Accounting for vaccines specificities in the Joint Clinical Assessment (JCA): a proposal for guiding principles: Sibilia Quilici

European journal of public health, 2022-10, Vol.32 (Suppl 3)

2022

Volltextzugriff (PDF)

Accounting for vaccines specificities in the Joint Clinical Assessment (JCA): a proposal for guiding principles

European journal of public health, 2022-10, Vol.32 (Supplement_3)

2022

Volltextzugriff (PDF)

HPR185 The International Impact of National Institute for Health and Care Excellence (NICE) Decisions

Value in health, 2022-12, Vol.25 (12), p.S266-S266

2022

Volltextzugriff (PDF)

HTA51 Challenges and Opportunities of Health Technology Assessment in Older Adult Immunization

Value in health, 2022-12, Vol.25 (12), p.S306-S306

2022

Volltextzugriff (PDF)

HTA261 Preparing for the EU Regulation on HTA and Joint Clinical Assessments of Vaccines

Value in health, 2023-12, Vol.26 (12), p.S370

2023

Volltextzugriff (PDF)

PIN20 EXPECTED COST-EFFECTIVENESS OF HIGH DOSE VERSUS ADJUVANTED STANDARD DOSE TRIVALENT INFLUENZA VACCINES IN ENGLAND AND WALES: ASSESSMENTS USING DIRECT AND INDIRECT COMPARATIVE EFFECTIVENESS DATA

Value in health, 2019-11, Vol.22, p.S643-S643

2019

Volltextzugriff (PDF)

PIN10 - Evaluation of the Number Needed to Vaccinate (NNV) with Gardasil9 in order to Avert 1 Case of Human Papillomavirus (HPV)-Related Anogenital Disease in France

Value in health, 2016-11, Vol.19 (7), p.A408-A408

2016

Volltextzugriff (PDF)

Evaluation of the Number Needed to Vaccinate (NNV) with Gardasil9 in order to Avert 1 Case of Human Papillomavirus (HPV)-Related Anogenital Disease in France

Value in health, 2016-11, Vol.19 (7), p.A408-A408

2016

Volltextzugriff (PDF)

PIN53 - Estimating The Cost-Effectiveness Profile of A Universal Vaccination Programme With A Nine-Valent Hpv Vaccine In Austria

Value in health, 2015-11, Vol.18 (7), p.A585-A585

2015

Volltextzugriff (PDF)

Estimating The Cost-Effectiveness Profile of A Universal Vaccination Programme With A Nine-Valent Hpv Vaccine In Austria

Value in health, 2015-11, Vol.18 (7), p.A585-A585

2015

Volltextzugriff (PDF)

Loss Of Opportunity Linked With The Suboptimal Coverage Rate Of Hpv Vaccination In France

Value in health, 2015-11, Vol.18 (7), p.A462-A462

2015

Volltextzugriff (PDF)

1 – 25 von 121

Suche als RSS-Feed

Aktive Filter

PublikationsformArtikel

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(112)
Mit Volltextzugriff
(110)

Sprache

Erscheinungsjahr

n.n

Thema

Internal Medicine
(22)
Science & Technology
(19)
Physical Sciences
(10)
Chemical Sciences
(9)
Humans
(8)
Life Sciences & Biomedicine
(8)
Organic Chemistry
(8)
Sciences Biologiques Et Medicales
(8)
Sciences Medicales
(8)
Chemistry
(7)
Analytical Chemistry
(6)
Chemistry, Organic
(6)
Middle Aged
(6)
Or Physical Chemistry
(6)
Theoretical And
(6)
Divers
(5)
Sante Publique. Hygiene-Medecine Du Travail
(5)
Santé Publique. Hygiène
(5)
Technology
(5)
Cost-Benefit Analysis
(4)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Estimating the cost-effectiveness profile of a universal vaccination programme with a nine-valent HPV vaccine in Austria

Évaluation du coût de la prise en charge pédiatrique des gastroentérites aiguës à rotavirus

Critical Review of Cost-Effectiveness Analyses (CEA) of Prevention Strategies Against Diseases Associated with Human Papillomavirus (HPV) Infection

The Economic Value of Vaccination: Why Prevention Is Wealth

Health and economic impact associated with a quadrivalent HPV vaccine in Italy

Épidémiologie et impact de la gastroentérite aiguë à rotavirus dans les crèches municipales de la ville de Lyon – saison 2004–2005

PRM17 Economic Evaluation of Vaccines: Considerations on Evidence, Discounting, Models and Futures Challenges

PIN60 Critical Review of Cost-Effectiveness Analyses of Human Papillomavirus Vaccine in Boys

Herpes Zoster in Europe: A Review of Evidence Documenting Humanistic, Economic and Societal Burden

Cost-Effectiveness Analysis of a Vaccination Programme for the Prevention of Herpes Zoster and Post-Herpetic Neuralgia in Adults Aged 50 and Over in Germany

PIN66 A Scoping Review of the Literature on the Multifactorial Health-Economics Burden Caused By the COVID-19 Pandemic

PCN165 A First Estimate of the Incremental Impact of Males HPV Vaccination on HPV-Related Diseases in Europe

Treatment patterns and associated costs for genital warts in Italy

Cost-effectiveness of vaccination against herpes zoster and postherpetic neuralgia: a critical review

Accounting for vaccines specificities in the Joint Clinical Assessment (JCA): a proposal for guiding principles: Sibilia Quilici

Accounting for vaccines specificities in the Joint Clinical Assessment (JCA): a proposal for guiding principles

HPR185 The International Impact of National Institute for Health and Care Excellence (NICE) Decisions

HTA51 Challenges and Opportunities of Health Technology Assessment in Older Adult Immunization

HTA261 Preparing for the EU Regulation on HTA and Joint Clinical Assessments of Vaccines

PIN20 EXPECTED COST-EFFECTIVENESS OF HIGH DOSE VERSUS ADJUVANTED STANDARD DOSE TRIVALENT INFLUENZA VACCINES IN ENGLAND AND WALES: ASSESSMENTS USING DIRECT AND INDIRECT COMPARATIVE EFFECTIVENESS DATA

PIN10 - Evaluation of the Number Needed to Vaccinate (NNV) with Gardasil9 in order to Avert 1 Case of Human Papillomavirus (HPV)-Related Anogenital Disease in France

Evaluation of the Number Needed to Vaccinate (NNV) with Gardasil9 in order to Avert 1 Case of Human Papillomavirus (HPV)-Related Anogenital Disease in France

PIN53 - Estimating The Cost-Effectiveness Profile of A Universal Vaccination Programme With A Nine-Valent Hpv Vaccine In Austria

Estimating The Cost-Effectiveness Profile of A Universal Vaccination Programme With A Nine-Valent Hpv Vaccine In Austria

Loss Of Opportunity Linked With The Suboptimal Coverage Rate Of Hpv Vaccination In France

Aktive Filter

Suchergebnisse filtern